Literature DB >> 18948836

Eosinophilia associated with chronic pancreatitis.

Qiang Wang1, Chong-Mei Lu, Tao Guo, Jia-Ming Qian.   

Abstract

OBJECTIVES: Eosinophilia (>0.5 x 10/L eosinophils [EOSs] in the peripheral blood) has been overlooked in the study of chronic pancreatitis (CP). The purpose of this study was to investigate the clinical significance and causes of eosinophilia by analyzing the features of CP cases with eosinophilia.
METHODS: We retrospectively analyzed the clinical features of CP patients with eosinophilia and compared them with CP patients without eosinophilia.
RESULTS: There were 28 cases (15.6%) of CP with eosinophilia among 180 CP patients. The ratio of male to female patients was 8.3:1. The mean patient age at the time of diagnosis was 49.0 (+/- 16.2) years. The peak value of EOSs in the patients' peripheral blood was 0.935 (+/- 0.600) x 10/L. The incidence of eosinophilia in autoimmune pancreatitis was significantly higher than in non-autoimmune pancreatitis CP cases. The incidence of pancreatic ascites, pancreatic enlargement, or jaundice in CP cases with eosinophilia was significantly higher than in those without eosinophilia. There was no obvious infiltration of EOSs in the pancreatic tissues of 16 pathology or cytology specimens.
CONCLUSIONS: The occurrence of eosinophilia during the course of CP is not unusual. This may be related to autoimmune mechanisms, serous membrane response, or the progression of pancreatic inflammation and fibrosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18948836     DOI: 10.1097/MPA.0b013e31818d8ecc

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

1.  Rare diagnosis of IgG4-related systemic disease by lip biopsy in an international Sjögren syndrome registry.

Authors:  Alan N Baer; Christine G Gourin; William H Westra; Darren P Cox; John S Greenspan; Troy E Daniels
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-11-10

Review 2.  Eosinophils in the pathogenesis of pancreatic disorders.

Authors:  Murli Manohar; Hemanth Kumar Kandikattu; Sathisha Upparahalli Venkateshaiah; Chandra Sekhar Yadavalli; Anil Mishra
Journal:  Semin Immunopathol       Date:  2021-03-30       Impact factor: 11.759

3.  Resolution of transient, marked eosinophilia, hyperimmunoglobulinemia E, and refractory eczematous dermatitis after the treatment of pancreatic pseudocysts.

Authors:  Toshiki Ito; Fumihide Iwata
Journal:  JAAD Case Rep       Date:  2015-07-31

4.  Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin.

Authors:  Tianlian Yan; Yini Ke; Yi Chen; Chengfu Xu; Chaohui Yu; Youming Li
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

Review 5.  Pathogenic mechanisms of pancreatitis.

Authors:  Murli Manohar; Alok Kumar Verma; Sathisha Upparahalli Venkateshaiah; Nathan L Sanders; Anil Mishra
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06

6.  Soy-tomato enriched diet reduces inflammation and disease severity in a pre-clinical model of chronic pancreatitis.

Authors:  Debasmita Mukherjee; Mallory J DiVincenzo; Molly Torok; Fouad Choueiry; Rahul J Kumar; Anna Deems; Jenna L Miller; Alice Hinton; Connor Geraghty; Jose Angel Maranon; Samuel K Kulp; Christopher Coss; William E Carson; Darwin L Conwell; Phil A Hart; Jessica L Cooperstone; Thomas A Mace
Journal:  Sci Rep       Date:  2020-12-11       Impact factor: 4.379

Review 7.  The Clinical Utility of Soluble Serum Biomarkers in Autoimmune Pancreatitis: A Systematic Review.

Authors:  Ana Dugic; Cristina Verdejo Gil; Claudia Mellenthin; Miroslav Vujasinovic; J-Matthias Löhr; Steffen Mühldorfer
Journal:  Biomedicines       Date:  2022-06-26

8.  Eosinophil peroxidase activates cells by HER2 receptor engagement and β1-integrin clustering with downstream MAPK cell signaling.

Authors:  Kerrie Hennigan; Paul J Conroy; Marie-Therese Walsh; Mohamed Amin; Richard O'Kennedy; Patmapriya Ramasamy; Gerald J Gleich; Zeshan Siddiqui; Senan Glynn; Olive McCabe; Catherine Mooney; Brian J Harvey; Richard W Costello; Jean McBryan
Journal:  Clin Immunol       Date:  2016-08-09       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.